Author:
Luo Yuan,Ahmad Faraz S.,Shah Sanjiv J.
Funder
National Institutes of Health
American Heart Association
American Heart Association (US)
Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine
Reference50 articles.
1. Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. (2015).Heart disease and stroke statistics—2016 update. A Report From the American Heart Association.
2. Yancy, C. W., Jessup, M., Bozkurt, B., et al. (2013). 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 62(16), e147–e239.
3. Samson, R., Jaiswal, A., Ennezat, P. V., Cassidy, M., & Le Jemtel, T. H. (2016). Clinical phenotypes in heart failure with preserved ejection fraction. Journal of the American Heart Association., 5(1), e002477.
4. Shah, S. J., Kitzman, D. W., Borlaug, B. A., et al. (2016). Phenotype-specific treatment of heart failure with preserved ejection fraction. A Multiorgan Roadmap., 134(1), 73–90.
5. Paulus, W. J., & Tschöpe, C. (2013). A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Journal of the American College of Cardiology, 62(4), 263–271.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献